Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study

Objective To compare the risk of acute myocardial infarction, heart failure, and death in patients with type 2 diabetes treated with rosiglitazone and pioglitazone.

Bibliographic Details
Main Authors: Juurlink, David N, Gomes, Tara, Lipscombe, Lorraine L, Austin, Peter C, Hux, Janet E, Mamdani, Muhammad M
Format: Online
Language:English
Published: BMJ Publishing Group Ltd. 2009
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728804/